M
Overview
Materialise is a 3D printing provider offering prototyping, serial manufacturing, and personalized healthcare solutions. It combines high-precision printing with software that manages print workflows, file preparation, and production planning, plus consultancy to optimize designs. It serves automotive, aerospace, engineering, and healthcare industries and earns revenue from printing services, software licenses, and consulting. Its goal is to help customers turn ideas into scalable production, improve healthcare personalization, and advance sustainable, customer-focused manufacturing from prototype to volume production.
Work here?Claim your company
Simplify's take
What believers are saying
- Q3 2026 revenue rose 2.1%, and adjusted EBIT guidance stays 12,000 to 14,000 kEUR.
- Materialise Medical grew 12.2% in Q2 2026, reinforcing the highest-quality segment.
- Management reinvested in Replasia on August 27, 2026, expanding personalized hip-care offerings.
What critics are saying
- Software revenue fell 2.7% in Q2 2026, exposing weak monetization outside Medical.
- Eyewear and RapidFit divestitures triggered impairments and shrank manufacturing breadth in 2026.
- Aerospace concentration and Medical leadership turnover threaten execution if replacement searches slip in 2027.
What makes Materialise unique
- Materialise dominates medical 3D printing, with Q3 2026 double-digit Medical growth.
- Its CO-AM software and end-to-end workflow stack embed customers across additive manufacturing.
- The company keeps deep aerospace and defense manufacturing know-how after RapidFit and Eyewear exits.
Help us improve and share your feedback! Did you find this helpful?